Anti-infective proteins in breast milk and asthma-associated phenotypes during early childhood

Guicheng Zhang1, Ching Tat Lai, Peter Hartmann

  • 1School of Public Health, Curtin University, Perth, WA, Australia.

Insights

Breast milk proteins may temporarily affect early childhood respiratory infections and allergies, but do not appear to influence asthma development. These transient effects suggest complex impacts on infant immune responses.

Area of Science:

  • Pediatric immunology
  • Allergy and immunology
  • Epidemiology

Background:

  • The relationship between breastfeeding and childhood asthma is debated, with confounding factors like respiratory infections and recall bias complicating previous research.
  • Existing studies often fail to adequately control for crucial confounders, leading to inconsistent findings on breast milk's protective effects.

Purpose of the Study:

  • To investigate the association between anti-infective protein concentrations in breast milk and respiratory infections, atopy, and asthma development in high-risk children.
  • To prospectively analyze these associations from birth to age 10 years, accounting for potential confounders.

Main Methods:

  • A prospective cohort study involving high-risk children.
  • Measurement of anti-infective protein concentrations in maternal milk samples.
  • Prospective follow-up for atopy, respiratory infections, and asthma diagnoses until age 10.

Main Results:

  • Transient inverse associations were observed between milk protein concentration and upper respiratory infections in the first year of life.
  • Parallel transient positive associations were found with early lower respiratory infections and atopy.
  • No significant associations were detected between breast milk protein concentrations and asthma-related outcomes up to age 10.

Conclusions:

  • Breast milk feeding may transiently influence inflammatory symptoms related to early-life respiratory infections and atopy.
  • The observed effects are inconsistent and short-lived, suggesting a complex and multi-level impact on infant immunoinflammatory function.
  • Breast milk's role in asthma development remains unclear, highlighting the need for further research into its immunomodulatory properties.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
69
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K